Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
60 tablets - Shipped Once
Tirzepatide (under the brand name Zepbound) was FDA approved for the treatment of obesity in November 2023
This blend is not approved by the FDA for human or veterinary use
During your consultation, I evaluate your medical history, examine your anatomy, and discuss your concerns to determine which treatments will be most effective for your unique situation
Currently, Ozempic Savings Program, Victoza Savings Program, Trulicity Savings Program, Rybelsus Savings Program, Mounjaro Savings Program, Zepbound Savings Program, and Wegovy Savings Program are offered by manufacturers of these medications
Daily dosing allows for flexible dose adjustments
US$ 20.17
US$ 23.89
US$ 26.88
